Michel T Corban Selected Research

Stents

6/2013

Fractional flow reserve for the assessment of complex multivessel disease in a patient after hybrid coronary revascularization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michel T Corban Research Topics

Disease

13	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 08/2012
6	Atherosclerosis 12/2021 - 06/2013
5	Stroke (Strokes) 01/2022 - 01/2020
5	Myocardial Infarction 12/2021 - 12/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2015
3	Heart Failure 01/2022 - 12/2018
3	Pathologic Constriction (Stenosis) 10/2020 - 01/2018
3	Diabetes Mellitus 10/2020 - 01/2020
3	Thrombosis (Thrombus) 01/2020 - 05/2017
2	Ischemia 01/2022 - 06/2013
2	Infarction (Infarctions) 01/2022 - 01/2020
2	Inflammation (Inflammations) 01/2021 - 07/2017
2	Chest Pain (Chest Pains) 10/2020 - 01/2020
2	ST Elevation Myocardial Infarction 01/2020 - 12/2018
2	Atherosclerotic Plaque (Atheroma) 01/2016 - 10/2012
1	Microvascular Angina (Cardiac Syndrome X) 01/2022
1	Dysbiosis 01/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021
1	Chronic Renal Insufficiency 10/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Rupture 01/2020
1	Hyperemia 01/2020
1	Hematoma 01/2019
1	Ventricular Tachycardia 12/2018
1	Autoimmune Diseases (Autoimmune Disease) 05/2017
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 05/2017
1	Venous Thromboembolism 05/2017

Drug/Important Bio-Agent (IBA)

6	omega-Chloroacetophenone (Mace)IBA 12/2021 - 12/2018
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2020 - 10/2012
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 03/2015
1	OsteocalcinIBA 01/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	Fibroblast Growth Factor-23IBA 01/2021
1	HomocysteineIBA 10/2020
1	HDL CholesterolIBA 10/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020
1	Vitamin B Complex (B Vitamins)IBA 10/2020
1	Triglycerides (Triacylglycerol)IBA 10/2020
1	LDL CholesterolIBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	SoilIBA 01/2020
1	Plasminogen InactivatorsIBA 01/2018
1	FibrinIBA 01/2018
1	LipidsIBA 07/2017
1	Antiphospholipid AntibodiesIBA 05/2017
1	Atenolol (Tenormin)FDA LinkGeneric 01/2016
1	Nebivolol FDA Link 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	Urokinase Plasminogen Activator ReceptorsIBA 03/2015
1	Atorvastatin (Lipitor)FDA Link 10/2012
1	P 11 (P-11)IBA 10/2012
1	CalciumIBA 10/2012
1	Phenobarbital (Luminal)FDA Link 08/2012

Therapy/Procedure

7	Therapeutics 01/2022 - 10/2012
2	Transplantation 01/2022 - 12/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Myocardial Revascularization 01/2022
1	Catheter Ablation 01/2019
1	Percutaneous Coronary Intervention 12/2018
1	Stents 06/2013